Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Drug Resistance

Free Subscription Articles published in AIDS Retrieve available abstracts of 15 articles: HTML format

Single Articles

November 2022
1. MILNE RS, Beck IA, Levine M, So I, et al
   Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy.
   AIDS. 2022;36:1949-1958.
   PubMed     Abstract available
   
   
   
2. DUARTE FC, Moura LM, Laranjinha J
   High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
   AIDS. 2022;36:1881-1882.
   PubMed    
   
   
   September 2022
3. CONWAY B, Brenner BG
   Can simplified antiretroviral drug combination therapies resist resistance?
   AIDS. 2022;36:1597-1598.
   PubMed    
   
   
   August 2022
4. WOOD BR, Stekler JD
   Baseline HIV genotype drug resistance testing: is it time for more or less?
   AIDS. 2022;36:1449-1451.
   PubMed    
   
   
   July 2022
5. HUIK K, Hill S, George J, Pau A, et al
   High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
   AIDS. 2022 Jul 11. pii: 00002030-990000000-00033.
   PubMed     Abstract available
   
   
   February 2022
6. HUGUELEY B, Mcclung RP, Saduvala N, Oster AM, et al
   Baseline HIV drug resistance testing: 12 U.S. jurisdictions, 2014-2019.
   AIDS. 2022 Feb 9. pii: 00002030-900000000-96222.
   PubMed     Abstract available
   
   
   
7. HERMANS LE, Hofstra LM, Schuurman R, Ter Heine R, et al
   HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment - week 96 results from the ITREMA trial.
   AIDS. 2022 Feb 1. pii: 00002030-900000000-96229.
   PubMed     Abstract available
   
   
   January 2022
8. GENER AR
   Anticipating HIV drug resistance with appropriate sequencing methods.
   AIDS. 2022;36:147-148.
   PubMed    
   
   
   October 2021
9. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
   HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
   AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
   PubMed     Abstract available
   
   
   
10. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed     Abstract available
    
    
    July 2021
11. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    PubMed     Abstract available
    
    
    June 2021
12. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    PubMed     Abstract available
    
    
    February 2021
13. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    PubMed     Abstract available
    
    
    
14. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    PubMed     Abstract available
    
    
    
15. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: